Skip to main content

Table 1 Clinical, anthropometric, and biochemical characteristics of the 307 study participants

From: Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease

Number of participants

307

Age, sex, and clinical data

 Age, years

60 (51–65)

 Women, %

49.5

 Obesity, %

58.7

 Type 2 diabetes, %

73.9

 Hypertension, %

55.1

 ASCVD, %

13.4

 Plaque, %

37.4

 cIMT, mm

0.69 (0.64–0.78)

Physical measurements

 BMI, kg/m2

30.7 (28.28–35.78)

 Waist circumference (cm)

104 (97–113)

 Systolic BP, mmHg

138 (128–150)

 Diastolic BP, mmHg

80 (75–87)

Biochemical data

 Total cholesterol, mmol/L

5.64 (4.88–6.83)

 Triglycerides, mmol/L

1.86 (1.24–3.08)

 VLDL-C, mmol/L

0.9 (0.56–1.32)

 LDL-C, mmol/L

3.54 ± 1.11

 HDL-C, mmol/L

1.11 (0.93–1.32)

 Non-HDL-C, mmol/L

4.46 (3.78–5.52)

 Apo B-100, mg/dL

118 (98–141)

 Apo A-I, mg/dL

121 (105–138)

 Glucose, mg/dL

133 (107–168)

 hsCRP, mg/L

2.23 (1.26–3.75)

 Glyc-A, µmol/L

895.14 (748.45–1099.62)

  1. Data are percentages (%) for categorical variables, medians (interquartile ranges) for nonparametric continuous variables or means ± SDs for continuous normally distributed variables
  2. ASCVD atherosclerotic cardiovascular disease, cIMT carotid intima-media thickness, BMI body mass index, systolic BP systolic blood pressure, diastolic BP diastolic blood pressure, VLDL-C very low-density lipoprotein cholesterol, LDL-C LDL cholesterol, HDL-C high-density lipoprotein cholesterol, Non-HDL-C non-HDL cholesterol, Apo B-100 apolipoprotein B100, Apo A-I apolipoprotein A1, hsCRP high-sensitivity C-reactive protein, Glyc-A glycoprotein A
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840